Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Short bowel syndrome (SBS) is an intestinal disorder associated with malabsorption due to the lack of functional intestine. SBS can be congenital or an acquired condition which can be observed in patients in whom nearly half of the small intestine has been removed due to underlying disease condition.
The medications prescribed for the treatment of SBS include teduglutide and growth hormones (aid in intestinal absorption), proton pump inhibitors (used to treat gastric acid secretions), and anti-diarrheal (to treat the primary symptom of SBS, i.e., diarrhea). As the patients with SBS have lost major part of the intestine, retaining nutrients in such patients through oral nutrition becomes difficult. Hence parenteral nutrition is the preferred mode of treatment in these patients.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Short Bowel Syndrome market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Short Bowel Syndrome market. Detailed analysis of key players, along with key growth strategies adopted by Short Bowel Syndrome industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Emmaus Life Sciences
Sancilio & Company
Ardelyx
OxThera
Nutrinia
Zealand Pharma
Naia Pharmaceuticals
Merck
Shire
GlyPharma Therapeutics
By Type:
GLP-2
Growth Hormone
Glutamine
Others
By End-User:
Hospitals
Clinics
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Short Bowel Syndrome Market
-
1.3 Market Segment by Type
-
1.3.1 USA Short Bowel Syndrome Market Size and Growth Rate of GLP-2 from 2016 to 2027
-
1.3.2 USA Short Bowel Syndrome Market Size and Growth Rate of Growth Hormone from 2016 to 2027
-
1.3.3 USA Short Bowel Syndrome Market Size and Growth Rate of Glutamine from 2016 to 2027
-
1.3.4 USA Short Bowel Syndrome Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Short Bowel Syndrome Market Size and Growth Rate of Hospitals from 2016 to 2027
-
1.4.2 USA Short Bowel Syndrome Market Size and Growth Rate of Clinics from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Short Bowel Syndrome Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Short Bowel Syndrome Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Short Bowel Syndrome Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Short Bowel Syndrome Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Short Bowel Syndrome Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Short Bowel Syndrome by Major Types
-
3.4.1 Market Size and Growth Rate of GLP-2
-
3.4.2 Market Size and Growth Rate of Growth Hormone
-
3.4.3 Market Size and Growth Rate of Glutamine
-
3.4.4 Market Size and Growth Rate of Others
4 Segmentation of Short Bowel Syndrome Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Short Bowel Syndrome by Major End-Users
-
4.4.1 Market Size and Growth Rate of Short Bowel Syndrome in Hospitals
-
4.4.2 Market Size and Growth Rate of Short Bowel Syndrome in Clinics
5 Market Analysis by Regions
-
5.1 USA Short Bowel Syndrome Production Analysis by Regions
-
5.2 USA Short Bowel Syndrome Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Short Bowel Syndrome Landscape Analysis
-
6.1 West USA Short Bowel Syndrome Landscape Analysis by Major Types
-
6.2 West USA Short Bowel Syndrome Landscape Analysis by Major End-Users
7 South USA Short Bowel Syndrome Landscape Analysis
-
7.1 South USA Short Bowel Syndrome Landscape Analysis by Major Types
-
7.2 South USA Short Bowel Syndrome Landscape Analysis by Major End-Users
8 Middle West USA Short Bowel Syndrome Landscape Analysis
-
8.1 Middle West USA Short Bowel Syndrome Landscape Analysis by Major Types
-
8.2 Middle West USA Short Bowel Syndrome Landscape Analysis by Major End-Users
9 Northeast USA Short Bowel Syndrome Landscape Analysis
-
9.1 Northeast USA Short Bowel Syndrome Landscape Analysis by Major Types
-
9.2 Northeast USA Short Bowel Syndrome Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Emmaus Life Sciences
-
10.1.1 Emmaus Life Sciences Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Sancilio & Company
-
10.2.1 Sancilio & Company Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Ardelyx
-
10.3.1 Ardelyx Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 OxThera
-
10.4.1 OxThera Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Nutrinia
-
10.5.1 Nutrinia Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Zealand Pharma
-
10.6.1 Zealand Pharma Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Naia Pharmaceuticals
-
10.7.1 Naia Pharmaceuticals Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Merck
-
10.8.1 Merck Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Shire
-
10.9.1 Shire Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
-
10.10 GlyPharma Therapeutics
-
10.10.1 GlyPharma Therapeutics Company Profile and Recent Development
-
10.10.2 Market Performance
-
10.10.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Short Bowel Syndrome Market Size and Growth Rate of GLP-2 from 2016 to 2027
-
Figure USA Short Bowel Syndrome Market Size and Growth Rate of Growth Hormone from 2016 to 2027
-
Figure USA Short Bowel Syndrome Market Size and Growth Rate of Glutamine from 2016 to 2027
-
Figure USA Short Bowel Syndrome Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Short Bowel Syndrome Market Size and Growth Rate of Hospitals from 2016 to 2027
-
Figure USA Short Bowel Syndrome Market Size and Growth Rate of Clinics from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Short Bowel Syndrome Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Short Bowel Syndrome Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Short Bowel Syndrome Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Short Bowel Syndrome Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Short Bowel Syndrome Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Short Bowel Syndrome
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Short Bowel Syndrome by Different Types from 2016 to 2027
-
Table Consumption Share of Short Bowel Syndrome by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of GLP-2
-
Figure Market Size and Growth Rate of Growth Hormone
-
Figure Market Size and Growth Rate of Glutamine
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Short Bowel Syndrome by Different End-Users from 2016 to 2027
-
Table Consumption Share of Short Bowel Syndrome by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hospitals
-
Figure Market Size and Growth Rate of Clinics
-
Table USA Short Bowel Syndrome Production by Regions
-
Table USA Short Bowel Syndrome Production Share by Regions
-
Figure USA Short Bowel Syndrome Production Share by Regions in 2016
-
Figure USA Short Bowel Syndrome Production Share by Regions in 2021
-
Figure USA Short Bowel Syndrome Production Share by Regions in 2027
-
Table USA Short Bowel Syndrome Consumption by Regions
-
Table USA Short Bowel Syndrome Consumption Share by Regions
-
Figure USA Short Bowel Syndrome Consumption Share by Regions in 2016
-
Figure USA Short Bowel Syndrome Consumption Share by Regions in 2021
-
Figure USA Short Bowel Syndrome Consumption Share by Regions in 2027
-
Table West USA Short Bowel Syndrome Consumption by Types from 2016 to 2027
-
Table West USA Short Bowel Syndrome Consumption Share by Types from 2016 to 2027
-
Figure West USA Short Bowel Syndrome Consumption Share by Types in 2016
-
Figure West USA Short Bowel Syndrome Consumption Share by Types in 2021
-
Figure West USA Short Bowel Syndrome Consumption Share by Types in 2027
-
Table West USA Short Bowel Syndrome Consumption by End-Users from 2016 to 2027
-
Table West USA Short Bowel Syndrome Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Short Bowel Syndrome Consumption Share by End-Users in 2016
-
Figure West USA Short Bowel Syndrome Consumption Share by End-Users in 2021
-
Figure West USA Short Bowel Syndrome Consumption Share by End-Users in 2027
-
Table South USA Short Bowel Syndrome Consumption by Types from 2016 to 2027
-
Table South USA Short Bowel Syndrome Consumption Share by Types from 2016 to 2027
-
Figure South USA Short Bowel Syndrome Consumption Share by Types in 2016
-
Figure South USA Short Bowel Syndrome Consumption Share by Types in 2021
-
Figure South USA Short Bowel Syndrome Consumption Share by Types in 2027
-
Table South USA Short Bowel Syndrome Consumption by End-Users from 2016 to 2027
-
Table South USA Short Bowel Syndrome Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Short Bowel Syndrome Consumption Share by End-Users in 2016
-
Figure South USA Short Bowel Syndrome Consumption Share by End-Users in 2021
-
Figure South USA Short Bowel Syndrome Consumption Share by End-Users in 2027
-
Table Middle West USA Short Bowel Syndrome Consumption by Types from 2016 to 2027
-
Table Middle West USA Short Bowel Syndrome Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Short Bowel Syndrome Consumption Share by Types in 2016
-
Figure Middle West USA Short Bowel Syndrome Consumption Share by Types in 2021
-
Figure Middle West USA Short Bowel Syndrome Consumption Share by Types in 2027
-
Table Middle West USA Short Bowel Syndrome Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Short Bowel Syndrome Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Short Bowel Syndrome Consumption Share by End-Users in 2016
-
Figure Middle West USA Short Bowel Syndrome Consumption Share by End-Users in 2021
-
Figure Middle West USA Short Bowel Syndrome Consumption Share by End-Users in 2027
-
Table Northeast USA Short Bowel Syndrome Consumption by Types from 2016 to 2027
-
Table Northeast USA Short Bowel Syndrome Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Short Bowel Syndrome Consumption Share by Types in 2016
-
Figure Northeast USA Short Bowel Syndrome Consumption Share by Types in 2021
-
Figure Northeast USA Short Bowel Syndrome Consumption Share by Types in 2027
-
Table Northeast USA Short Bowel Syndrome Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Short Bowel Syndrome Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Short Bowel Syndrome Consumption Share by End-Users in 2016
-
Figure Northeast USA Short Bowel Syndrome Consumption Share by End-Users in 2021
-
Figure Northeast USA Short Bowel Syndrome Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Emmaus Life Sciences
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Emmaus Life Sciences
-
Figure Sales and Growth Rate Analysis of Emmaus Life Sciences
-
Figure Revenue and Market Share Analysis of Emmaus Life Sciences
-
Table Product and Service Introduction of Emmaus Life Sciences
-
Table Company Profile and Development Status of Sancilio & Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sancilio & Company
-
Figure Sales and Growth Rate Analysis of Sancilio & Company
-
Figure Revenue and Market Share Analysis of Sancilio & Company
-
Table Product and Service Introduction of Sancilio & Company
-
Table Company Profile and Development Status of Ardelyx
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ardelyx
-
Figure Sales and Growth Rate Analysis of Ardelyx
-
Figure Revenue and Market Share Analysis of Ardelyx
-
Table Product and Service Introduction of Ardelyx
-
Table Company Profile and Development Status of OxThera
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of OxThera
-
Figure Sales and Growth Rate Analysis of OxThera
-
Figure Revenue and Market Share Analysis of OxThera
-
Table Product and Service Introduction of OxThera
-
Table Company Profile and Development Status of Nutrinia
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Nutrinia
-
Figure Sales and Growth Rate Analysis of Nutrinia
-
Figure Revenue and Market Share Analysis of Nutrinia
-
Table Product and Service Introduction of Nutrinia
-
Table Company Profile and Development Status of Zealand Pharma
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zealand Pharma
-
Figure Sales and Growth Rate Analysis of Zealand Pharma
-
Figure Revenue and Market Share Analysis of Zealand Pharma
-
Table Product and Service Introduction of Zealand Pharma
-
Table Company Profile and Development Status of Naia Pharmaceuticals
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Naia Pharmaceuticals
-
Figure Sales and Growth Rate Analysis of Naia Pharmaceuticals
-
Figure Revenue and Market Share Analysis of Naia Pharmaceuticals
-
Table Product and Service Introduction of Naia Pharmaceuticals
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Shire
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire
-
Figure Sales and Growth Rate Analysis of Shire
-
Figure Revenue and Market Share Analysis of Shire
-
Table Product and Service Introduction of Shire
-
Table Company Profile and Development Status of GlyPharma Therapeutics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlyPharma Therapeutics
-
Figure Sales and Growth Rate Analysis of GlyPharma Therapeutics
-
Figure Revenue and Market Share Analysis of GlyPharma Therapeutics
-
Table Product and Service Introduction of GlyPharma Therapeutics
-
